Hospital Clínic de Barcelona, officially Hospital Clínic i Provincial de Barcelona, is a university hospital founded in 1906 and based in Barcelona. It opened its doors on December 23, 1906, with a capacity of 400 patients, some of which were moved from Hospital de la Santa Creu.

There are 819 beds in Fundació Clínic per a la Recerca Biomèdica.

During the past decade, Fundació Clínic per a la Recerca Biomèdica conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundació Clínic per a la Recerca Biomèdica" #1 sponsor was "Fundacion Clinic per a la Recerca Biomédica" with 1 trials, followed by "Hospital Clinic of Barcelona" with 1 trials sponsored, "Jordi Alonso" with 1 trials sponsored, "Nestor Soler Porcar, MD, PhD" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundació Clínic per a la Recerca Biomèdica" #1 collaborator was "Instituto de Salud Carlos III" with 2 trials as a collaborator, "Agència de Qualitat i Avaluació Sanitàries" with 1 trials as a collaborator, "Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina" with 1 trials as a collaborator, "Fundacion Clinic per a la Recerca Biomédica" with 1 trials as a collaborator and "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Fundació Clínic per a la Recerca Biomèdica" are "Chronic Obstructive Pulmonary Disease" (2 trials), "Adverse Reaction to Drugs Affecting the Gastrointestinal System" (1 trials), "Anxiety" (1 trials), "Covid19" (1 trials) and "Cranial Sutures; Closure" (1 trials). Many other conditions were trialed in "Fundació Clínic per a la Recerca Biomèdica" in a lesser frequency.

Most popular intervention types in "Fundació Clínic per a la Recerca Biomèdica" are "Drug" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Counselling" (1 trials), "Dural closure" (1 trials), "Isavuconazole" (1 trials), "Left atrial appendage occlusion" (1 trials) and "Moxifloxacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundació Clínic per a la Recerca Biomèdica" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Fundació Clínic per a la Recerca Biomèdica". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fundació Clínic per a la Recerca Biomèdica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundació Clínic per a la Recerca Biomèdica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".